Meet Embecta! Becton Dickinson Completes Diabetes Spin-Off

 
• By Reed Miller

Becton Dickinson has formally completed the planned spin-off of its diabetes business within the timeframe it projected about a year ago. The new company, called embecta, is one of the largest producers of diabetes injection devices.

Insulin and glucose molecules in blood • Source: Alamy

More from Deals

More from Business